[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__RiskMitigation_595 

# __Ace2 and tmprss2 inhibitors__

## Category to which it belongs

* [Investigating droplet physics, improving surveillance, addressing over-exposure, international collaboration, raising awareness, and more for a comprehensive response to the pandemic.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_459.md)

## Closest similar item

* [Implement advanced treatment processes, such as ozonation or membrane filtration, to improve removal efficiency of sars-cov-2 rna.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3040.md)
* [Continue research and development of vaccines against sars-cov-2.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3062.md)
* [Improve specificity of pcr assays to distinguish between sars-cov-2 and other coronaviruses.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3039.md)
* [Conduct research to understand the tissue tropism and pathogenesis of sars-cov-2.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3059.md)
* [Development of drug therapies](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1294.md)
* [Non-pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_377.md)
* [Utilize ai algorithms for drug discovery and development of novel treatments.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2857.md)
* [Conduct research to determine the mechanisms of cell entry and membrane fusion of sars-cov-2.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3058.md)
* [Drug development](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_599.md)
* [Validate and optimize pcr assays to ensure accurate detection of sars-cov-2 genetic material.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3038.md)

## Benefits linked to a risk

* [Pathogenesis](https://github.com/mm80843/T3.5/blob/main/docs/Benef/PBN__Benef_591.md)

## Risks possibly mitigated by this Mitigation

* [Tissue tropism](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_428.md)

